Cost-effectiveness targeting CLL

Research output: Contribution to journalEditorialResearchpeer-review

Original languageEnglish
JournalBlood
Volume136
Issue number17
Pages (from-to)1896-1898
ISSN0006-4971
DOIs
Publication statusPublished - 2020

    Research areas

  • Adenine/analogs & derivatives, Cost-Benefit Analysis, Humans, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Piperidines, Pyrazoles, Pyrimidines

ID: 261535324